Corrigendum: Adaptive and innate immune responses in multiple sclerosis with anti-CD20 therapy: gene expression and protein profiles

Bibliographic Details
Main Authors: Chloe C. Fong, Julian Spencer, Quentin Howlett-Prieto, Xuan Feng, Anthony T. Reder
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-08-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2023.1245622/full
_version_ 1797751304012955648
author Chloe C. Fong
Julian Spencer
Quentin Howlett-Prieto
Xuan Feng
Anthony T. Reder
author_facet Chloe C. Fong
Julian Spencer
Quentin Howlett-Prieto
Xuan Feng
Anthony T. Reder
author_sort Chloe C. Fong
collection DOAJ
first_indexed 2024-03-12T16:45:28Z
format Article
id doaj.art-5aa2ab0d88634a74b2540920d957c4df
institution Directory Open Access Journal
issn 1664-2295
language English
last_indexed 2024-03-12T16:45:28Z
publishDate 2023-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neurology
spelling doaj.art-5aa2ab0d88634a74b2540920d957c4df2023-08-08T12:21:50ZengFrontiers Media S.A.Frontiers in Neurology1664-22952023-08-011410.3389/fneur.2023.12456221245622Corrigendum: Adaptive and innate immune responses in multiple sclerosis with anti-CD20 therapy: gene expression and protein profilesChloe C. FongJulian SpencerQuentin Howlett-PrietoXuan FengAnthony T. Rederhttps://www.frontiersin.org/articles/10.3389/fneur.2023.1245622/fullanti-CD20 therapyB cellmultiple sclerosisocrelizumabT cellTLR
spellingShingle Chloe C. Fong
Julian Spencer
Quentin Howlett-Prieto
Xuan Feng
Anthony T. Reder
Corrigendum: Adaptive and innate immune responses in multiple sclerosis with anti-CD20 therapy: gene expression and protein profiles
Frontiers in Neurology
anti-CD20 therapy
B cell
multiple sclerosis
ocrelizumab
T cell
TLR
title Corrigendum: Adaptive and innate immune responses in multiple sclerosis with anti-CD20 therapy: gene expression and protein profiles
title_full Corrigendum: Adaptive and innate immune responses in multiple sclerosis with anti-CD20 therapy: gene expression and protein profiles
title_fullStr Corrigendum: Adaptive and innate immune responses in multiple sclerosis with anti-CD20 therapy: gene expression and protein profiles
title_full_unstemmed Corrigendum: Adaptive and innate immune responses in multiple sclerosis with anti-CD20 therapy: gene expression and protein profiles
title_short Corrigendum: Adaptive and innate immune responses in multiple sclerosis with anti-CD20 therapy: gene expression and protein profiles
title_sort corrigendum adaptive and innate immune responses in multiple sclerosis with anti cd20 therapy gene expression and protein profiles
topic anti-CD20 therapy
B cell
multiple sclerosis
ocrelizumab
T cell
TLR
url https://www.frontiersin.org/articles/10.3389/fneur.2023.1245622/full
work_keys_str_mv AT chloecfong corrigendumadaptiveandinnateimmuneresponsesinmultiplesclerosiswithanticd20therapygeneexpressionandproteinprofiles
AT julianspencer corrigendumadaptiveandinnateimmuneresponsesinmultiplesclerosiswithanticd20therapygeneexpressionandproteinprofiles
AT quentinhowlettprieto corrigendumadaptiveandinnateimmuneresponsesinmultiplesclerosiswithanticd20therapygeneexpressionandproteinprofiles
AT xuanfeng corrigendumadaptiveandinnateimmuneresponsesinmultiplesclerosiswithanticd20therapygeneexpressionandproteinprofiles
AT anthonytreder corrigendumadaptiveandinnateimmuneresponsesinmultiplesclerosiswithanticd20therapygeneexpressionandproteinprofiles